SCHEMBL127746

SCHEMBL127746

Clc1ccc(C2CCCCC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.57
SLC18A3 Q16572 1/20 0.55
DRD2 P14416 1/20 0.50
BCL2L1 Q07817 2/20 0.48
MCL1 Q07820 2/20 0.48
ALOX15B O15296 1/20 0.46
ALDH1A1 P00352 1/20 0.46
SERPINE1 P05121 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
LSS P48449 1/20 0.43
KMT2A Q03164 3/20 0.43
SRD5A1 P18405 2/20 0.43
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22870548 1.00 HTR3A (0.57) HTR3ASLC18A3DRD2BCL2L1MCL1
SCHEMBL8125540 1.00 HTR3A (0.57) HTR3ASLC18A3DRD2BCL2L1MCL1
SCHEMBL218475 0.97 HTR3A (0.59) HTR3ASLC18A3DRD2BCL2L1MCL1
Methyl Alcohol SCHEMBL28438875 0.93 SLC18A3 (0.54) HTR3ASLC18A3DRD2BCL2L1MCL1
SCHEMBL19090025 0.93 HTR3A (0.52) HTR3ASLC18A3DRD2BCL2L1MCL1
SCHEMBL435619 0.92 HTR3A (0.59) HTR3ASLC18A3DRD2ALDH1A1SMN1; SMN2
Methyl Alcohol SCHEMBL8471414 0.91 SLC18A3 (0.56) HTR3ASLC18A3DRD2BCL2L1MCL1
SCHEMBL9938123 0.89 BCL2L1 (0.52) HTR3ASLC18A3BCL2L1MCL1ALDH1A1
Bicarbonate SCHEMBL6204994 0.89 BCL2L1 (0.56) HTR3ASLC18A3BCL2L1MCL1SERPINE1
SCHEMBL13004487 0.88 HTR3A (0.47) HTR3ASLC18A3DRD2BCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104718200-B Thiophene derivant for treating diabetes 蒙塔博瑞恩研究公司 2016-11-09 CN claimed
CN-104718200-A Thiophene derivatives used in the treatment of diabetes METABRAIN RES 2015-06-17 CN claimed
US-20070148554-A1 Non-aqueous electrolytic solution and lithium secondary battery UBE INDUSTRIES, LTD. (JP) 2007-06-28 US claimed
CN-1938894-A Nonaqueous electrolyte solution and lithium secondary battery UBE INDUSTRIES (JP) 2007-03-28 CN claimed
US-20060178403-A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto NEUROCRINE BIOSCIENCES, INC. (US) 2006-08-10 US claimed
US-7067509-B2 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto NEUROCRINE BIOSCIENCES, INC. (US) 2006-06-27 US claimed
US-20040259931-A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto NEUROCRINE BIOSCIENCES, INC. 2004-12-23 US claimed
WO-2004081005-A1 MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AND COMPOSITIONS AND METHODS RELATED THERETO NEUROCRINE BIOSCIENCES, INC. (US) 2004-09-23 WO claimed
WO-2004080411-A2 MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AND COMPOSITIONS AND METHODS RELATED THERETO NEUROCRINE BIOSCIENCES, INC. (US) 2004-09-23 WO claimed
EP-4305026-B1 ANTI-INFLAMMATORY CARBOXAMIDE DERIVATIVES BIOMEDCODE HELLAS SA (GR) 2025-05-07 EP disclosed
CN-119431102-A Halogenated cyclohexylbenzene compound and preparation method thereof 棓诺(张家港)新材料有限公司 2025-02-14 CN disclosed
US-11788009-B2 Liquid-crystalline medium for use in a switching element MERCK PATENT GMBH (DE) 2023-10-17 US disclosed
EP-4215526-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF Shanghai Pharmaceuticals Holding Co., Ltd. (CN) 2023-07-26 EP disclosed
US-11702597-B2 Azo dye MERCK PATENT GMBH (DE) 2023-07-18 US disclosed
EP-0340581-A2 Process for the chlorination in the nucleus of aromatic hydrocarbons BAYER AG (DE) 1989-11-08 EP disclosed
US-4851596-A Process for nucleus-chlorination of aromatic hydrocarbons BAYER AKTIENGESELLSCHAFT (DE) 1989-07-25 US disclosed
EP-0247366-A1 Electrically conducting polymer film and method of manufacturing the same NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) 1987-12-02 EP disclosed
US-4559112-A INSULATING POLUMER FILM OF SURFACE OF ELECTRODE AROMATIC POLYMER FORMEDAT INTERFACE BETWEEN/ FILM AND ELECTRODE NIPPON TELEGRAPH & TELEPHONE (JP) 1985-12-17 US disclosed
EP-0144127-A1 Electrically conducting polymer film and method of manufacturing the same NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) 1985-06-12 EP disclosed
US-4173463-A Phosphonium salts as herbicides SHELL OIL COMPANY (US) 1979-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259931-A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto MCHR1, MCHR2, MC1R HTR3A 51/4885SLC18A3 390/4885DRD2 265/4885
US-20060178403-A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto MCHR1, MCHR2, MC1R HTR3A 77/4885SLC18A3 334/4885DRD2 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.